Supplement: LA SB394 | 2022 | Regular Session | Fiscal Note - SB394 ReEngrossed With House Cmte Amendments
For additional supplements on Louisiana SB394 please see the Bill Drafting List
Bill Title: Requires coverage for drugs under certain conditions and the drug is approved by the United States Food and Drug Administration. (1/1/23) (EN INCREASE SG EX See Note)
Status: 2022-06-18 - Effective date 1/1/2023. [SB394 Detail]
Download: Louisiana-2022-SB394-Fiscal_Note_-_SB394_ReEngrossed_With_House_Cmte_Amendments.pdf
Bill Title: Requires coverage for drugs under certain conditions and the drug is approved by the United States Food and Drug Administration. (1/1/23) (EN INCREASE SG EX See Note)
Status: 2022-06-18 - Effective date 1/1/2023. [SB394 Detail]
Download: Louisiana-2022-SB394-Fiscal_Note_-_SB394_ReEngrossed_With_House_Cmte_Amendments.pdf
